Integra LifeSciences Holdings
IART
$16.64+2.27%
End of day · as of Sep 30, 2026, 9:01 AM ET
Mkt cap
$1.32B
EV/Sales
1.11
P/E ratio
N/A
FY2025 Revenue
$1.64B
EPS (FY2025)
$-6.74
Gross Margin (FY2025)
50.86%
Profit Margin (FY2025)
-31.58%
Beta
1.25
Div yield
N/A
Sector
Healthcare
Integra LifeSciences Holdings (IART) is a medical devices company listed on US.
Latest reported IART revenue for 2025-12-31 was $1.64B. Net income was -$516.5M. Revenue was up 1.5% from 2024-12-31 to 2025-12-31. IART currently screens at market cap $1.32B.
Use this IART research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full IART income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Integra LifeSciences Holdings (IART) is a medical devices company in the Healthcare sector.
Latest cached Integra LifeSciences Holdings (IART) revenue for Dec 31, 2025 was $1.64B. Net income was -$516.5M. Statements: https://lician.com/financials/iart
Integra LifeSciences Holdings (IART) market capitalization is $1.32B on the latest cached snapshot.
Integra LifeSciences Holdings (IART) cached previous close $16.27; day range $15.80 – $16.77; volume 1,005,098. Session quote: https://lician.com/quote/iart
Integra LifeSciences Holdings (IART) latest cached earnings event is "IART earnings" on Jul 30, 2026. Earnings calendar: https://lician.com/earnings
The latest cached IART filing is 8-K · Oct 9, 2026. Filings: https://lician.com/sec/iart